The importance of staging systems for the determination of prognosis of well-differentiated thyroid cancer
- PMID: 25931834
- PMCID: PMC4379769
- DOI: 10.5152/UCD.2013.02
The importance of staging systems for the determination of prognosis of well-differentiated thyroid cancer
Abstract
Objective: In this study, we aimed to determine the significance of the staging systems (EORTC, De Groot, MACIS, and TNM) on the prognosis of well-differentiated thyroid cancer patients who underwent surgery in our clinics.
Material and methods: This retrospective study included 181 patients who were operated between December 1995-December 2007, with a diagnosis of thyroid cancer. In order to obtain data related to cancer staging, a computer program for PDA was developed to facilitate parameter recording. Survival analysis was performed. The findings were compared to the predicted rates by the staging systems.
Results: According to the De Groot staging system, stage 1 and stage 2 patients' results were compatible, but stage 3 and 4 patients' results were different (stage 3; 87% versus 66.6%, stage 4; 35% versus 100%, p=0.04). In the MACIS staging system, 20-year survival rates are determined and comparison should not be made due to insufficient follow-up period in this study. When compared to the EORTC staging system, stage 3 and stage 4 patients' results were determined different (stage 3; 51% versus 100%, stage 4; 33% versus 50%, p=0.02). The most consistent results in terms of prognosis was determined in comparison with the TNM staging system (stage 1; 100% versus 97.8%, stage 4; 45.3% versus 50%).
Conclusion: Many classification systems are proposed for well-differentiated thyroid cancer, to predict the behavior of the tumor. In this study, we concluded that for determination of prognosis in well-differentiated thyroid cancer, the TNM staging system could best predict prognosis consistent with clinical findings.
Keywords: Thyroid cancer; prognosis; staging systems.
References
-
- Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev. 2005;31:423–38. http://dx.doi.org/10.1016/j.ctrv.2005.04.009. - DOI - PubMed
-
- Biersack HJ, Grünwald F. Thyroid Cancer. Second edition. Springer Verlag; Berlin Heidelberg New York: 2005. pp. 1–21. http://dx.doi.org/10.1007/3-540-27845-1. - DOI
-
- Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Handbook: TNM Classification of malignant Tumors. 6th ed. New York: Springer-Verlag; 2002. http://dx.doi.org/10.1007/978-1-4757-3656-4. - DOI
-
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010. pp. 87–96.
-
- Kukora JS. Tiroid Kanseri. In: Cameron JL, editor. Current Surgical Treatment-1. Vol. 11. Avrupa Tıp Kitapçılık; İstanbul: 2001. pp. 583–9.
LinkOut - more resources
Full Text Sources
Other Literature Sources